drugset / Trial / NCT00363155
KRN7000 in Chronic Hepatitis B
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this trial is to determine the safety, tolerability and effectiveness of KRN7000 for chronic hepatitis B infection.
Timeline
- Start
- 2003-03
- Primary completion
- —
- Completion
- 2006-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RGI-7000 | Small molecule | 0.1 ug/kg | — |
| Subject | RGI-7000 | Small molecule | 1 ug/kg | — |
| Subject | RGI-7000 | Small molecule | 10 ug/kg | — |